Literature DB >> 30240520

Hypercalcemia and cancer: Differential diagnosis and treatment.

Jonathan Zagzag1, Mimi I Hu2, Sarah B Fisher1, Nancy D Perrier3.   

Abstract

Incidentally detected hypercalcemia usually presents in an indolent manner and is most likely caused by primary hyperparathyroidism. In contrast, hypercalcemia in the patient with a history of cancer presents in a wide range of clinical settings and may be severe enough to warrant hospitalization. This form of hypercalcemia is usually secondary to hypercalcemia of malignancy and can be fatal. Hypercalcemia of malignancy is most commonly mediated by tumoral production of parathyroid hormone-related protein or by cytokines activating osteoclast degradation of bone. The initial workup, differential diagnoses, confirmatory laboratory testing, imaging, and medical and surgical management of hypercalcemia are described in the patient with cancer.
© 2018 American Cancer Society.

Entities:  

Keywords:  evaluation; malignancy; management; paraneoplastic syndrome

Mesh:

Substances:

Year:  2018        PMID: 30240520     DOI: 10.3322/caac.21489

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  19 in total

1.  Recurrent hypercalcaemia in a patient with dual urological malignancies: A rare life-threatening entity.

Authors:  Srimanta K Haldar; Anshuman Sarkar; Aditi Gupta; Gaurav Aggarwal
Journal:  Indian J Anaesth       Date:  2022-06-06

2.  Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinoma.

Authors:  Samuel M Miller; Lauren E Wilson; Melissa A Greiner; Jessica E Pritchard; Tian Zhang; Deborah R Kaye; Harvey Jay Cohen; Robert D Becher; Linda L Maerz; Michaela A Dinan
Journal:  J Geriatr Oncol       Date:  2022-01-05       Impact factor: 3.929

3.  Pancreatitis: TIGAR-O Version 2 Risk/Etiology Checklist With Topic Reviews, Updates, and Use Primers.

Authors:  David C Whitcomb
Journal:  Clin Transl Gastroenterol       Date:  2019-06       Impact factor: 4.488

4.  Cinacalcet for the Treatment of Humoral Hypercalcemia of Malignancy: An Introductory Case Report with a Pathophysiologic and Therapeutic Review.

Authors:  Michael Sheehan; Sabo Tanimu; Yusuf Tanimu; Jessica Engel; Adedayo Onitilo
Journal:  Case Rep Oncol       Date:  2020-03-25

5.  Serum Calcium Levels Before Antitumour Therapy Predict Clinical Outcomes in Patients with Nasopharyngeal Carcinoma.

Authors:  Sheng-Yan Huang; Yang Chen; Xi-Rong Tan; Sha Gong; Xiao-Jing Yang; Qing-Mei He; Shi-Wei He; Na Liu; Ying-Qing Li
Journal:  Onco Targets Ther       Date:  2020-12-23       Impact factor: 4.147

6.  Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers.

Authors:  Elisa Giannetta; Franz Sesti; Roberta Modica; Erika Maria Grossrubatscher; Valentina Guarnotta; Alberto Ragni; Isabella Zanata; Annamaria Colao; Antongiulio Faggiano
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-19       Impact factor: 5.555

Review 7.  Fatigue as the Chief Complaint–Epidemiology, Causes, Diagnosis, and Treatment.

Authors:  Peter Maisel; Erika Baum; Norbert Donner-Banzhoff
Journal:  Dtsch Arztebl Int       Date:  2021-08-23       Impact factor: 8.251

8.  An Atypical Presentation of Primary Hyperparathyroidism in an Adolescent: A Case Report of Hypercalcaemia and Neuropsychiatric Symptoms Due to a Mediastinal Parathyroid Adenoma.

Authors:  Roberta Minelli; Aniello Meoli; Alessandra Tiri; Umberto Fanelli; Rosanna Iannarella; Pierpacifico Gismondi; Susanna Esposito
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-29       Impact factor: 5.555

9.  Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients.

Authors:  Li Bao; Yutong Wang; Minqiu Lu; Bin Chu; Lei Shi; Shan Gao; Lijuan Fang; Qiuqing Xiang
Journal:  Cancer Med       Date:  2020-11-04       Impact factor: 4.452

10.  Calcium-Sensing Receptor Polymorphisms at rs1801725 Are Associated with Increased Risk of Secondary Malignancies.

Authors:  Ky'Era V Actkins; Heather K Beasley; Annika B Faucon; Lea K Davis; Amos M Sakwe
Journal:  J Pers Med       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.